Authors:
Dziadulewicz, EK
Walpole, CS
Snell, CR
Wrigglesworth, R
Hughes, GA
Beattie, D
Wood, JN
Beech, MM
Coote, PR
Citation: Ek. Dziadulewicz et al., Design of non-peptide CCK2 and NK1 peptidomimetics using 1-(2-nitrophenyl)thiosemicarbazide as a novel common scaffold, BIOORG MED, 11(5), 2001, pp. 705-709
Authors:
Dziadulewicz, EK
Ritchie, TJ
Hallett, A
Snell, CR
Ko, SY
Wrigglesworth, R
Hughes, GA
Dunstan, AR
Bloomfield, GC
Drake, GS
Brown, MC
Lee, W
Burgess, GM
Davis, C
Yaqoob, M
Perkins, MN
Campbell, EA
Davis, AJ
Rang, HP
Citation: Ek. Dziadulewicz et al., 1-(2-nitrophenyl)thiosemicarbazides: A novel class of potent, orally active non-peptide antagonist for the bradykinin B-2 receptor, J MED CHEM, 43(5), 2000, pp. 769-771
Authors:
Burnouf, C
Auclair, E
Avenel, N
Bertin, B
Bigot, C
Calvet, A
Chan, K
Durand, C
Fasquelle, V
Feru, F
Gilbertsen, R
Jacobelli, H
Kebsi, A
Lallier, E
Maignel, J
Martin, B
Milano, S
Ouagued, M
Pascal, Y
Pruniaux, MP
Puaud, J
Rocher, MN
Terrasse, C
Wrigglesworth, R
Doherty, AM
Citation: C. Burnouf et al., Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indoles:Discovery of potent, selective phosphodiesterase type 4 inhibitors, J MED CHEM, 43(25), 2000, pp. 4850-4867
Authors:
Burgess, GM
Perkins, MN
Rang, HP
Campbell, EA
Brown, MC
McIntyre, P
Urban, L
Dziadulewicz, EK
Ritchie, TJ
Hallett, A
Snell, CR
Wrigglesworth, R
Lee, W
Davis, C
Phagoo, SB
Davis, AJ
Phillips, E
Drake, GS
Hughes, GA
Dunstan, A
Bloomfield, GC
Citation: Gm. Burgess et al., Bradyzide, a potent non-peptide B-2 bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia, BR J PHARM, 129(1), 2000, pp. 77-86